Literature DB >> 11810182

Induction of the complement component C1qB in brain of transgenic mice with neuronal overexpression of human cyclooxygenase-2.

Lauren Spielman1, David Winger, Lap Ho, Paul S Aisen, Esther Shohami, Giulio Maria Pasinetti.   

Abstract

We report that overexpression of human (h) cyclooxygenase-2 h(COX-2) in the brain of a transgenic mouse line leads to selective induction of endogenous complement component C1qB expression in neurons. No detectable induction of the C3 and C4 complement components in the brain was found. Chronic treatment of mice with the selective COX-2 inhibitor nimesulide reduced the hCOX-2-mediated induction of hippocampal C1qB mRNA expression. The data suggest that neuronal COX-2 expression may influence inflammatory responses in the brain, in part through modulation of complement gene expression. Because there is extensive evidence that C1q and other complement components are involved in Alzheimer's disease (AD) neurodegeneration, this study advances our understanding of the apparent benefits of COX-2 inhibition in AD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11810182     DOI: 10.1007/s004010100447

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  11 in total

1.  Neuronal overexpression of cyclooxygenase-2 does not alter the neuroinflammatory response during brain innate immune activation.

Authors:  Saba Aid; Nishant Parikh; Sara Palumbo; Francesca Bosetti
Journal:  Neurosci Lett       Date:  2010-05-06       Impact factor: 3.046

2.  Kindling-induced learning deficiency and possible cellular and molecular involved mechanisms.

Authors:  Mohammad Amin Sherafat; Abdolaziz Ronaghi; Leila Ahmad-Molaei; Mohammad Nejadhoseynian; Rasoul Ghasemi; Arman Hosseini; Nima Naderi; Fereshteh Motamedi
Journal:  Neurol Sci       Date:  2012-06-29       Impact factor: 3.307

3.  Cyclooxygenase-2-specific inhibitor improves functional outcomes, provides neuroprotection, and reduces inflammation in a rat model of traumatic brain injury.

Authors:  Jonas J Gopez; Hongfei Yue; Ram Vasudevan; Amir S Malik; Lester N Fogelsanger; Shawn Lewis; David Panikashvili; Esther Shohami; Susan A Jansen; Raj K Narayan; Kenneth I Strauss
Journal:  Neurosurgery       Date:  2005-03       Impact factor: 4.654

4.  Cyclooxygenase-2 promotes amyloid plaque deposition in a mouse model of Alzheimer's disease neuropathology.

Authors:  Zhongmin Xiang; Lap Ho; Shrishailam Yemul; Zhong Zhao; Wein Qing; Patrick Pompl; Kevin Kelley; Anju Dang; Weiping Qing; David Teplow; Giulio Maria Pasinetti
Journal:  Gene Expr       Date:  2002

5.  Measurement by ELISA of complement factor 4 (C4) in the rat brain: necessity for removal of cerebrovascular proteins.

Authors:  David A Loeffler; Dianne M Camp
Journal:  Neurochem Res       Date:  2006-07-18       Impact factor: 3.996

Review 6.  Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brain.

Authors:  Kenneth I Strauss
Journal:  Brain Behav Immun       Date:  2007-11-08       Impact factor: 7.217

7.  Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer's disease.

Authors:  Jun Zhou; Maria I Fonseca; Karntipa Pisalyaput; Andrea J Tenner
Journal:  J Neurochem       Date:  2008-07-09       Impact factor: 5.372

8.  Transcriptome profiling of whole blood cells identifies PLEK2 and C1QB in human melanoma.

Authors:  Yuchun Luo; Steven Robinson; Junichi Fujita; Lisa Siconolfi; Jay Magidson; Carl K Edwards; Karl Wassmann; Kathleen Storm; David A Norris; Danute Bankaitis-Davis; William A Robinson; Mayumi Fujita
Journal:  PLoS One       Date:  2011-06-15       Impact factor: 3.240

9.  Effects of the cyclooxygenase-2 inhibitor nimesulide on cerebral infarction and neurological deficits induced by permanent middle cerebral artery occlusion in the rat.

Authors:  Eduardo Candelario-Jalil; Noël H Mhadu; Armando González-Falcón; Michel García-Cabrera; Eduardo Muñoz; Olga Sonia León; Bernd L Fiebich
Journal:  J Neuroinflammation       Date:  2005-01-18       Impact factor: 8.322

10.  Functional microRNAs in Alzheimer's disease and cancer: differential regulation of common mechanisms and pathways.

Authors:  Kelly N Holohan; Debomoy K Lahiri; Bryan P Schneider; Tatiana Foroud; Andrew J Saykin
Journal:  Front Genet       Date:  2013-01-17       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.